AI AND ANNEX 22
Current Landscape of Implementing AI on a GxP Enviroment
Free Webinar
Join our live webinar to gain a practical understanding of the challenges of implementing AI in GxP-regulated environments, and what the current draft of Annex 22 means for your computerized systems.
📆Date: 02nd December 2026
🕐 Time: 2:30 PM UTC | Duration: 35 min
💻 Platform: Microsoft Teams
Webinar Overview
In this live webinar, our expert will guide you through the current regulatory landscape for AI in the pharmaceutical industry, including the EU AI Act and the current draft of Annex 22. You will also gain practical insights into the challenges of implementing and validating AI-based computerized systems in GxP environments, and explore when AI is truly the right solution to optimize a process.
Key Objectives
- Give insights on the current challenges the pharma industry faces in the age of AI
- Discuss the existing regulations on AI and their applicability on the pharmaceutical industry
- Discuss the current draft of Annex 22 and what is expected of the published version
- Examine the main differences in validating a Computerized System using an AI model
- Explain the obstacles of optimizing a process using AI
Programme Content
- Context and scope
- The EU AI Act and what is expected from regulators
- Annex 22 – Current draft and expected changes
- CSV on AI based systems
- AI, Automation and digitalization – Is AI the best solution to optimize a procedure?
Registration
To secure your participation, please complete the registration form.